These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37004660)

  • 21. The impact of lymphadenectomy on the survival outcomes of ovarian clear cell carcinoma: A retrospective study of the SEER database and Chinese registry.
    Liu Y; Zhao W; Huang C; Chu R; Li Z; Wang Y; Song L; Li L
    Eur J Surg Oncol; 2024 Mar; 50(3):107975. PubMed ID: 38295548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.
    Matsuo K; Yoshino K; Hasegawa K; Murakami R; Ikeda Y; Adachi S; Hiramatsu K; Yokoyama T; Nishimura M; Sheridan TB; Enomoto T; Fujiwara K; Matsumura N; Konishi I; Fotopoulou C; Roman LD; Sood AK
    Gynecol Oncol; 2015 Feb; 136(2):198-204. PubMed ID: 25497604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic profiling of ovarian clear cell carcinoma in Chinese patients reveals potential prognostic biomarkers for survival.
    Ye S; Zhou S; Wu Y; Pei X; Jiang W; Shi W; Yang W; Zhou X; Shan B; Yang H
    Ann Med; 2023 Dec; 55(1):2218104. PubMed ID: 37272300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.
    Oseledchyk A; Leitao MM; Konner J; O'Cearbhaill RE; Zamarin D; Sonoda Y; Gardner GJ; Long Roche K; Aghajanian CA; Grisham RN; Brown CL; Snyder A; Chi DS; Soslow RA; Abu-Rustum NR; Zivanovic O
    Ann Oncol; 2017 Dec; 28(12):2985-2993. PubMed ID: 28950307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian clear cell carcinoma, outcomes by stage: the MSK experience.
    Shu CA; Zhou Q; Jotwani AR; Iasonos A; Leitao MM; Konner JA; Aghajanian CA
    Gynecol Oncol; 2015 Nov; 139(2):236-41. PubMed ID: 26404183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twenty-eight months progression-free survival after pyrotinib therapy for HER2-positive recurrent ovarian clear cell carcinoma: a case report.
    Wu J; You Y; Zhuang R; Guo X; Zhang C; Zhang Q; Zhou Y; Li Q
    Ann Transl Med; 2022 Mar; 10(6):387. PubMed ID: 35433993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clear cell carcinoma of the ovary: Clinicopathologic features and outcomes in a Chinese cohort.
    Tang H; Liu Y; Wang X; Guan L; Chen W; Jiang H; Lu Y
    Medicine (Baltimore); 2018 May; 97(21):e10881. PubMed ID: 29794794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma.
    Li J; Cao D
    Front Oncol; 2022; 12():956380. PubMed ID: 36387090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma.
    Ju UC; Kang WD; Kim SM
    Int J Gynaecol Obstet; 2019 Aug; 146(2):177-183. PubMed ID: 31081117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of lymphadenectomy on ovarian clear cell carcinoma: a systematic review and meta-analysis.
    Liu Y; Geng F; Zhang H; Xue J; Chu R
    World J Surg Oncol; 2024 Jan; 22(1):37. PubMed ID: 38287354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma.
    Liu X; Lu H; Zhou Y; Long X; Li Q; Zhuang G; Yin X; Di W
    Cancer Med; 2023 May; 12(10):11385-11395. PubMed ID: 36971044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometriosis is the independent prognostic factor for survival in Chinese patients with epithelial ovarian carcinoma.
    Ren T; Wang S; Sun J; Qu JM; Xiang Y; Shen K; Lang JH
    J Ovarian Res; 2017 Oct; 10(1):67. PubMed ID: 28974236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma.
    Yamazaki H; Todo Y; Shimada C; Takeshita S; Minobe S; Okamoto K; Yamashiro K; Kato H
    J Gynecol Oncol; 2018 Mar; 29(2):e19. PubMed ID: 29400012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Adjuvant Chemotherapy on FIGO Stage I Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Yin M; Yang J; Zhou H; Liu Q; Li S; Zhang X
    Front Oncol; 2022; 12():811638. PubMed ID: 35656506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for ethnic and environmental contributions to frequency of ovarian clear cell carcinoma.
    Tay SK; Cheong MA
    Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):225-30. PubMed ID: 24888594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ovarian clear cell carcinoma derived from endometriotic cyst: a clinicopathological analysis of 54 cases].
    Zhu Q; Lu Y; Rao Y; Ning Y; Qu Y; Wang L; Zhou X
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):838-42. PubMed ID: 26887772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of bevacizumab and secondary cytoreductive surgery on survival outcomes in platinum-sensitive relapsed ovarian clear cell carcinoma: A multicenter study in Korea.
    Kim SI; Kim JH; Noh JJ; Kim SH; Kim TE; Kim K; Park JY; Lim MC; Lee JW; Kim JW
    Gynecol Oncol; 2022 Sep; 166(3):444-452. PubMed ID: 35863991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Laparoscopic Surgery Does Not Affect the Prognosis of Early-Stage Ovarian Clear Cell Cancer.
    Yin S; Gao W; Shi P; Xi M; Tang W; Zhang J
    Cancer Manag Res; 2021; 13():6403-6409. PubMed ID: 34421313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unexpected primary fallopian tube carcinoma during gynecological operations: Clinicopathological and prognostic factors analyses of 67 cases.
    Sun M; Bao L; Shen H; Ji M; Yao L; Yi X; Jiang W
    Taiwan J Obstet Gynecol; 2019 Sep; 58(5):626-632. PubMed ID: 31542083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.